AIM
XRAY icon

ARK Investment Management’s Dentsply Sirona XRAY Stock Holding History

ARK Investment Management’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Sell
235,538
-31,210
-12% -$341K 0.02% 132
2026
Q1 		$3.09M Sell
266,748
-76,418
-22% -$953K 0.02% 111
2025
Q4 		$3.92M Buy
343,166
+116,623
+51% +$1.37M 0.03% 122
2025
Q3 		$2.87M Buy
226,543
+13,584
+6% +$197K 0.02% 136
2025
Q2 		$3.38M Buy
212,959
+52,186
+32% +$780K 0.02% 117
2025
Q1 		$2.4M Buy
160,773
+23,448
+17% +$415K 0.02% 125
2024
Q4 		$2.61M Sell
137,325
-312
-0.2% -$6.6K 0.02% 124
2024
Q3 		$3.72M Buy
137,637
+1,688
+1% +$43.1K 0.03% 119
2024
Q2 		$3.39M Buy
135,949
+205
+0.2% +$5.88K 0.03% 124
2024
Q1 		$4.51M Buy
135,744
+17,329
+15% +$592K 0.03% 135
2023
Q4 		$4.21M Sell
118,415
-9,827
-8% -$312K 0.03% 131
2023
Q3 		$4.38M Buy
+128,242
New +$4.88M 0.03% 132

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

ARK Investment Management's XRAY Position: Q2 2026 in Review

ARK Investment Management reduced its Dentsply Sirona (XRAY) stake by 12% in Q2 2026, selling an estimated $341K and leaving 235,538 shares worth $2.5M. The position accounts for 0.02% of the portfolio, ranked #132.

ARK Investment Management first reported a position in XRAY in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.51M in Q1 2024. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • ARK Investment Management held 235,538 shares of Dentsply Sirona worth $2.5M as of Q2 2026.
  • ARK Investment Management sold 31,210 Dentsply Sirona shares in Q2 2026, an estimated $341K.
  • Dentsply Sirona made up 0.02% of ARK Investment Management's portfolio in Q2 2026, its #132 holding.
  • ARK Investment Management first reported a position in Dentsply Sirona in Q3 2023 and has held it in 12 quarters since.
  • ARK Investment Management's Dentsply Sirona position peaked at $4.51M in Q1 2024.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.